Concepedia

M. Wilkinson

MW

Statistics

Publications

3

Citations

148

H-Index

3

Active since

1983

Affiliations

Hematology Oncology Associates(Current)

Rutgers Cancer Institute

M. Wilkinson is an author at Hematology Oncology Associates specializing in her2-positive breast cancer therapy, tyrosine kinase inhibitor therapy, and loperamide therapy.

Publications per year

1983–2020

3

Publications

3

Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial

CH Barcenas, Sara A. Hurvitz, Jack A. Di Palma et al. · Annals of Oncology · 2020 · 106 citations · Full text

, , +17

Increased arterial pressure variability after arterial baroreceptor denervation in fetal lambs.

Robert Yardley, Glenn Bowes, M. Wilkinson et al. · Circulation Research · 1983 · 28 citations

, , +13

Abstract P3-14-01: Effects of adding budesonide or colestipol to loperamide prophylaxis on neratinib-associated diarrhea in patients with HER2+ early-stage breast cancer: The CONTROL trial

Sara A. Hurvitz, Arlene Chan, Nicholas Iannotti et al. · Cancer Research · 2018 · 14 citations

, , +17

1–3 of 3